New-onset cardiac amyloidosis while in remission from systemic AL amyloidosis

• DOI: 10.12890/2023_003768
• Publication Date: 2023-02-09T09:12:51Z
• Authors: Abiodun Idowu; Lillian Tung; Catherine Chu; Jamario Skeete; Agne Paner; Tochukwu Okwuosa
• Keywords: AL amyloidosis; Cardiac Amyloidosis; Amyloid (mycology)

In light chain amyloidosis, a reduction in dFLC to below 40 mg/l is prerequisite for organ recovery as nearly half of the patients who achieve very good partial haematological responses have improvement function involved organ. We describe patient developed new-onset cardiac amyloidosis despite post-treatment <10 mg/l.Patients with (AL) may develop new involvement achieving remission.In AL response (dFLC mg/l) does not obviate need regular monitoring.